PA
Probity Advisors’s GSK GSK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $910K | Buy |
23,685
+4,484
| +23% | +$172K | 0.16% | 98 |
|
|
2025
Q1 | $744K | Buy |
19,201
+4,081
| +27% | +$158K | 0.14% | 112 |
|
|
2024
Q4 | $511K | Buy |
15,120
+5,599
| +59% | +$189K | 0.1% | 140 |
|
|
2024
Q3 | $389K | Sell |
9,521
-119
| -1% | -$4.87K | 0.07% | 176 |
|
|
2024
Q2 | $371K | Buy |
9,640
+460
| +5% | +$17.7K | 0.08% | 171 |
|
|
2024
Q1 | $394K | Sell |
9,180
-759
| -8% | -$32.5K | 0.08% | 165 |
|
|
2023
Q4 | $368K | Buy |
9,939
+2,084
| +27% | +$77.2K | 0.08% | 162 |
|
|
2023
Q3 | $285K | Buy |
7,855
+2,168
| +38% | +$78.6K | 0.07% | 157 |
|
|
2023
Q2 | $203K | Buy |
+5,687
| New | +$203K | 0.04% | 185 |
|